Christopher Hite

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Hite:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP & Vice Chairman Class A Ordinary Shares 658,510 $23,232,232 $35.28 05 Nov 2025 By SCH Investment Partners LLC
Royalty Pharma plc EVP & Vice Chairman Class A Ordinary Shares 70,000 $2,469,600 $35.28 05 Nov 2025 Direct
Royalty Pharma plc EVP & Vice Chairman Class E Ordinary Shares 1,238,789 16 May 2025 Indirect
Royalty Pharma plc EVP & Vice Chairman LP interests in RPI US Partners 2019, LP 86,641 14 Feb 2025 By SCH Investment Partners LLC
ACCELERON PHARMA INC Director Common Stock 0 $175.00 19 Nov 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 19 Nov 2021 Direct

Insider Reports Filed by Christopher Hite

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 05 Nov 2025 1 $0 4 EVP & Vice Chairman 07 Nov 2025, 16:18
RPRX Royalty Pharma plc 06 Aug 2025 1 $0 4 EVP & Vice Chairman 08 Aug 2025, 16:54
RPRX Royalty Pharma plc 16 May 2025 1 $0 4 EVP & Vice Chairman 20 May 2025, 16:54
RPRX Royalty Pharma plc 08 May 2025 1 $0 4 EVP & Vice Chairman 09 May 2025, 17:14
RPRX Royalty Pharma plc 14 Feb 2025 2 $0 4 EVP & Vice Chairman 18 Feb 2025, 17:16
RPRX Royalty Pharma plc 13 May 2024 2 $0 4 EVP & Vice Chairman 16 May 2024, 17:42
/report/000110465921142278-hite-christopher-2021-11-19 ACCELERON PHARMA INC 19 Nov 2021 3 $0 4 Director 22 Nov 2021, 08:10